arteparon 250 mg ml injection - Résultats de recherche

Australie - anglais - Department of Health (Therapeutic Goods Administration)

fragmin dalteparin sodium 7500 anti-xa iu/0.75ml injection syringe (graduated)

pfizer australia pty ltd - dalteparin sodium, quantity: 7500 anti-xa iu - injection, solution - excipient ingredients: water for injections; sodium chloride - prophylaxis against thrombotic complications during haemodialysis and treatment of acute deep vein thrombosis (dvt). extended treatment of symptomatic venous thromboembolism (vte) (proximal deep vein thrombosis and/or pulmonary embolism) to reduce the recurrence of vte in patients with solid tumour cancers. treatment of unstable coronary artery disease, i.e. unstable angina and non-st-elevation myocardial infarction (also known as non-q-wave myocardial infarction). prophylaxis against thrombo-embolic complications in the peri- or postoperative period of surgery.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

fragmin dalteparin sodium 5,000 anti-xa iu/0.2ml injection syringe

pfizer australia pty ltd - dalteparin sodium, quantity: 5000 anti-xa iu - injection, solution - excipient ingredients: water for injections - prophylaxis against thrombotic complications during haemodialysis and treatment of acute deep vein thrombosis (dvt). extended treatment of symptomatic venous thromboembolism (vte) (proximal deep vein thrombosis and/or pulmonary embolism) to reduce the recurrence of vte in patients with solid tumour cancers. treatment of unstable coronary artery disease, i.e. unstable angina and non-st-elevation myocardial infarction (also known as non-q-wave myocardial infarction). prophylaxis against thrombo-embolic complications in the peri- or postoperative period of surgery.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

fragmin dalteparin sodium 2,500 anti-xa iu/0.2ml injection syringe

pfizer australia pty ltd - dalteparin sodium, quantity: 2500 anti-xa iu - injection, solution - excipient ingredients: water for injections; sodium chloride - prophylaxis against thrombotic complications during haemodialysis and treatment of acute deep vein thrombosis (dvt). extended treatment of symptomatic venous thromboembolism (vte) (proximal deep vein thrombosis and/or pulmonary embolism) to reduce the recurrence of vte in patients with solid tumour cancers. treatment of unstable coronary artery disease, i.e. unstable angina and non-st-elevation myocardial infarction (also known as non-q-wave myocardial infarction). prophylaxis against thrombo-embolic complications in the peri- or postoperative period of surgery.